Skip to main content
Explore URMC

Wilmot Cancer Institute Logo

menu
Megan A. Baumgart, M.D.
Megan A. Baumgart, M.D.

Megan A. Baumgart, M.D.

Medicine — Hematology/Oncology — Internal Medicine

Accepting New Patients

Megan A. Baumgart, M.D.

Medicine — Hematology/Oncology — Internal Medicine

Accepting New Patients


Locations

James P. Wilmot Cancer Center
601 Elmwood Ave.
Box 704
Rochester, NY 14642
Get Directions

phone

Appointments

(585) 275-5823

print

Fax

(585) 273-1042

About Me

I chose the field of oncology because I want to help patients through one of the most difficult experiences a person can have.

Cancer treatment requires a team approach involving the patient, medical oncologist, nurses and support staff, as well as other medical teams such as radiation oncology and surgery who are often part of a patient's care. I work with patients to help them understand the overall treatment plan – especially the role of chemotherapy in the treatment of their disease – and support them throughout the course of treatment.

I am optimistic about the future of cancer treatment and want to work towards finding new and better treatment strategies for lung and head and neck cancers through the development of our clinical trials program. We currently have several clinical trials evaluating the role of immunotherapy for the treatment of metastatic head and neck cancers open for enrollment, as well as other clinical trials focused on answering important questions regarding the management of these diseases.

Conditions I Treat

- Small cell lung cancer
- Non-small cell lung cancer
- Head and neck cancers
- Thyroid cancer

Credentials

Education:

MD | Albany Medical College of Union University — 2007

Post-doctoral Training & Residency:

Internship in Internal Medicine at Rhode Island Hospital — 2007 - 2008
Residency in Internal Medicine at Rhode Island Hospital — 2008 - 2010
Fellowship in Medical Oncology at Yale New Haven Hospital — 2011 - 2014

Research

Publications:

Abu-Khalaf, M. M.; Baumgart, M. A.; Gettinger, S. N.; Doddamane, I.; Tuck, D. P.; Hou, S.; Chen, N.; Sullivan, C.; Lezon-Geyda, K.; Zelterman, D.; Hatzis, C.; Deshpande, H.; Digiovanna, M. P.; Azodi, M.; Schwartz, P. E.; Harris, L. N. "Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin–bound paclitaxel in patients with advanced solid tumors". Cancer. 2015; 121(11): 1817-1826.